More articles from Metabolism, Transport, and Pharmacogenomics

Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People

Evolution of the Systems Pharmacokinetics-Pharmacodynamics Model for Antibody-Drug Conjugates to Characterize Tumor Heterogeneity and In Vivo Bystander Effect

ABCG2 Deficiency Does Not Alter Dolutegravir Metabolism and Pharmacokinetics

Hepatic Transporter Alterations by Nuclear Receptor Agonist T0901317 in Sandwich-Cultured Human Hepatocytes: Proteomic Analysis and PBPK Modeling to Evaluate Drug-Drug Interaction Risk